需求文献:
1、DAWSON PA, KARPEN SJ. Bile acids reach out to the spinal cord: new insights to the
pathogenesis of itch and analgesia in cholestatic liver disease [J]. Hepatology, 2014,
59 (4):1638-1641.
2、Kremer AE, van Dijk R, Leckie P, et al. Serum autotaxin is increased in pruirtus of
cholestasis, but not of other oirgin, and responds to therapeutic interventions[J].
Hepatology, 2012(56): 1391-1400.
3、Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment
of primary biliary cholangitis. Sumeyye Samur,Matthew Klebanoff,Reiner Banken,Daniel S.
Pratt. 《Hepatology》 , 2017 , 65 (3) :920.
4、Obeticholic acid for PBC. Hugh Thomas. Nature Reviews Gastroenterology & Hepatology 13,
558-559 (2016).
5、Emerging and future therapies for nonalcoholic steatohepatitis in adults. Gesthimani
Mintziori , Stergios A. Polyzos. 《Expert Opinion on Pharmacotherapy》 , 2016 , 17 (14) :1
-10.
6、9、Obeticholic acid for the treatment of primary biliary cirrhosis. Trivedi PJ,
Hirschfield GM, Gershwin ME. Expert Rev Clin Pharmacol. 2016;9(1):13-26.
doi:10.1586/17512433.2015.1092381. Epub 2015 Nov 7.
7、Kowdley K,Nevens F,Andreone P,et al. The first new trials for primary biliary
cirrhosis in a decade: an international program evaluating the farnesoid X receptor agonist
obeticholic acid[J]. Gastroenterology,2015,1481 ( 4) : S991-S992.
8、Treatment of Non-Alcoholic Fatty Liver Disease . Scherer A., Dufour J.-F.
9、Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers. Pencek R,
Marmon T, Roth JD, Liberman A, Hooshmand-Rad R, Young MA. Diabetes Obes Metab. 2016 Sep;18
(9):936-40. doi: 10.1111/dom.12681. Epub 2016 Jun 6.
10、Metabolite profiling of CHO cells with different growth characteristic
11、Sun, Zhaoyun; Peng, Xinhua; Dong, Xiongzi; Shi, Wenwen - Asian Journal of Chemistry,
2012, vol. 24, # 2, p. 929 - 930
要求:下载符合需求的文献PDF格式打包上传
[更多]